Influence of tumour size and uptake of 99mTc-octreotide on radio-guided surgery for neuroendocrine tumours

Minerva Endocrinologica

Volumn 34, Issue 2, 2009, Pages 89-96

  Hodolic M ^a   Fettich, J ^a   Rubello, D ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Neuroendocrine tumours; Octreotide; Radionuclide imaging

Indexed keywords

OCTREOTIDE; TECHNETIUM 99M; 99MTC OCTREOTIDE; 99MTC-OCTREOTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER SCINTISCANNING; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MOLECULAR PROBE; MORPHOLOGY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; RADIOACTIVITY; RADIOSURGERY; CANCER STAGING; COMPUTER ASSISTED SURGERY; FOLLOW UP; IMAGE ENHANCEMENT; MEDICAL RECORD; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; OCTREOTIDE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 70349768373     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bishop AE, Polak JM. Classification of Neuroendocrine Tumours. Clinical Endocrine Oncology. Oxford: Blackwell Science Ltd 1997:369-76.
2. Solcia E, Kloppel G, Sobin LH. Histological Typing of Endocrine Tumours. WHO International Classification of tumours. Berlin: Springer; 1999.
3. Gabriel M, Decristoforo C. An intrapatient Comparison of 99mTc EDDA HYNIC TOC with 111 In DTPA Octreotide for diagnosis of Somatostatin receptor expressing tumours. Journal of Nuclear Medicine 2003;44:708-167
4. Reubi JC. Clinical relevance of somatostin receptor imaging. Eur J Nucl Med 1994;131:575-6.
5. Bombardieri E, Seregni E, Villano C, Chiti A, Bajetta E. Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumours. Q J Nucl Med Mol Imaging 2004;48:150-63. (Pubitemid 39248302)
6. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, et al. Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. Neuroendocrinology 2004;80:394-424.
7. Kwekkeboom D, Krenning EP, de Jog M. Peptide Receptor Imaging and Therapy. J Nucl Med 2000;41:1704-13.
8. Krenning E, Kwekkeboom D, Reubi J, Hagen P, Eijck C, Oei H et al. 111In-octreotide scintigraphy in oncology. Digestion 1993;54:84-7.
9. Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li S et al. Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs. Current Pharmaceutical Design 2002;8:1781-807.
10. Reubi J, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristic, functional correlates and clinical implications. Journal of Steroid Biochemistry and Molecular Biology 1992;43:27-35.
11. Reubi JC, Kvols L, Krennig E, Lamberts SW. Distribution of somatostatin receptors in normal and tumours tissue. Metabolism 1990;39:78-81.
12. Briganti V, Matteini M, Ferri P, Vaggelli L, Castagnoli A, Pieroni C, et al. Octreoscan SPECT evaluation in the diagnosis of pancreas neuroendocrine tumours. Cancer Biother Radiopharm 2001;16:515-24. (Pubitemid 34024439)
13. de Herder WW, Lamberts SW. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 2002;14:53-7.
14. Von Guggenberg E, Sarg E, Lindtner H, Alafort L, Mather S, Moncayo R, et al. Preparation via coligand exchange and characterization of 99m-Tc-EDDA-HYNIC-D-Phe1, Tyr3-octreotide (99m-Tc-EDDA/HYNIC-TOC). J Label Compd Radiopharm 2003;46:307-18.
15. Kolenc P, Fettich J, Slodnjak I, Hojker S. Comparison of 99mTc-EDDA/HYNIC-TOC and 111In-DTPA-octreotide uptake in patients without know pathology. Eur J Nucl Med Mol Imaging 2004; 31(suppl 2):358 (abs).
16. Vidergar-Kralj B, Îagar I, Schwarzbartl-Pevec A. Novej‰i nuklearno-medicinski postopki pri netipljivih lezijah v dojki. Radiol Oncol 2004;38(Suppl 1):99-103.
17. Octreoscan® scintigraphy for gastroenteropancreatic neuroendocrine tumours. MSCA application 1003, Final assessment report 1999.
18. Filosso PL, Rena O, Ruffini E, Oliaro A. Intraoperative OctreoScan and Management of Bronchial Carcinoid. Chest 2002;122:1493-4.
19. Martin DT, Hinkle GH, Tuttle S. Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector. Am J Surg 1985;150:672-5. (Pubitemid 16213301)
20. Snoj M. Uporaba intraoperativnih gama detektorjev v onkolo‰ki kirurgiji. Onkologija 2002;6:11-3.
21. Cirillo F, Bottini A, Lima G, Alquati P. Radioguided surgery in the treatment of gastro-entero-pancreatic neuroendocrine tumors. Minerva Chir. 2000;55:517-21.
22. Albertario S, Forti P, Bianchi C, Morone G, Tinozzi FP, Moglia P et al. Radioguided surgery for gastrinoma: a case report Tumori 2002;88:41-2.
23. Hodolic M, Fettich J, Repse S, Peitl P, Lezaic L, Hojker S. Factors influencing radioguided surgery of neuroendocrine tumours using 99mTc-ethylenediamine N,N′-diacetic acid/6-Hydrazinopyridine-3-carboxylic acid-D-Phe1-Tyr3-octreotide. Nucl Med Commun. 2008;29:311-7.
24. Bangard M, Behe M, Guhlke S, Otte R, Bender H, Maecke HR et al. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D- Phe1-Tyr3-octreotide: with 111In-DTPA-D-Phe1-octreotide. Eur J Nucl Med 2000;27:628-37.
25. Rubello D, Salvatori M, Pelizzo MR, Rampin L, Fanti S, Gregianin M, et al. Radio-guided surgery of differentiated thyroid cancer using 131I or 99mTc-Sestamibi. Nuclear Medicine Communications 2006;27:1-4. (Pubitemid 44391832)
26. Martin DT, Hinkle GH, Tuttle S. Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector. Am J Surg 1985;150:672-5. (Pubitemid 16213301)
27. Hubalewska-Dydejczyk A, Kulig J, Szybinski P, Mikolajczak R, Pach D, Sowa-Staszczak A et al. Radioguided surgery with the use of 99mTc-EDDA/HYNIC- octreotate in intraoperative detection of neuroendocrine tumors of gastrointestinal trac. Eur J Nucl Med Mol Imaging 2007;34:1545-55.
28. Mure A, Lebtahi R, Labriolle-Vaylet C, Askienazy S. Imagerie des récepteurs de la somatostatine dans les tumeurs neuroendocrines gastroentéropancréatiques. Gastroenterol Clin Biol 1998;22:809-18.
29. Lebtahi R, Cadiot G, Marmuse JP, Vissuzaine C, Petegnief Y, Courillon-Mallet A et al. False-positive somatostatin receptor scintigraphy due to an accessory spleen. J Nucl Med 1997;38:1979-81. (Pubitemid 28030934)
30. Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S. Evaluation of surgical gamma probes for radioguided sentinel node localization. Eur j Nucl Med 1998;25:1224-31. (Pubitemid 28446046)